ANGLE plc (AGL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ANGLE plc (AGL) has a cash flow conversion efficiency ratio of -0.385x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-4.50 Million ≈ $-547.76 USD) by net assets (GBX11.69 Million ≈ $1.42K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ANGLE plc (AGL) total market value for the company's overall valuation and market capitalisation.
ANGLE plc - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how ANGLE plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ANGLE plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ANGLE plc ranked by their cash flow conversion efficiency. Explore earnings quality score of ANGLE plc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tap Global Group Plc
LSE:TAP
|
3.296x |
|
Altona Rare Earths PLC
LSE:REE
|
-0.494x |
|
Green Leaf Innovations Inc.
NASDAQ:GRLFD
|
N/A |
|
DOLPHIN DRILL. A.S. NK 10
F:L33
|
N/A |
|
CRISM Therapeutics Corporation
LSE:CRTX
|
-0.775x |
|
Global Partner Acq Corp
NASDAQ:GPACU
|
0.297x |
|
CORE ASSETS CORP.
F:5RJ
|
N/A |
|
Trafalgar New Homes Plc
LSE:TRAF
|
-0.117x |
Annual Cash Flow Conversion Efficiency for ANGLE plc (2001–2024)
The table below shows the annual cash flow conversion efficiency of ANGLE plc from 2001 to 2024. View ANGLE plc share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX18.44 Million ≈ $2.24K |
GBX-13.45 Million ≈ $-1.64K |
-0.729x | -15.70% |
| 2023-12-31 | GBX22.94 Million ≈ $2.79K |
GBX-14.46 Million ≈ $-1.76K |
-0.630x | -57.33% |
| 2022-12-31 | GBX40.06 Million ≈ $4.87K |
GBX-16.05 Million ≈ $-1.95K |
-0.401x | -15.32% |
| 2021-12-31 | GBX40.33 Million ≈ $4.91K |
GBX-14.01 Million ≈ $-1.70K |
-0.347x | -52.02% |
| 2020-12-31 | GBX34.34 Million ≈ $4.18K |
GBX-7.85 Million ≈ $-954.87 |
-0.229x | +27.02% |
| 2019-12-31 | GBX26.60 Million ≈ $3.24K |
GBX-8.33 Million ≈ $-1.01K |
-0.313x | +17.22% |
| 2019-04-30 | GBX19.34 Million ≈ $2.35K |
GBX-7.31 Million ≈ $-889.90 |
-0.378x | +11.80% |
| 2018-04-30 | GBX15.88 Million ≈ $1.93K |
GBX-6.81 Million ≈ $-828.82 |
-0.429x | +48.85% |
| 2017-04-30 | GBX8.81 Million ≈ $1.07K |
GBX-7.38 Million ≈ $-898.30 |
-0.838x | +7.83% |
| 2016-04-30 | GBX5.24 Million ≈ $636.95 |
GBX-4.76 Million ≈ $-579.40 |
-0.910x | -168.19% |
| 2015-04-30 | GBX10.09 Million ≈ $1.23K |
GBX-3.42 Million ≈ $-416.36 |
-0.339x | +16.30% |
| 2014-04-30 | GBX5.51 Million ≈ $671.02 |
GBX-2.23 Million ≈ $-271.93 |
-0.405x | -97.56% |
| 2013-04-30 | GBX6.79 Million ≈ $825.71 |
GBX-1.39 Million ≈ $-169.38 |
-0.205x | +16.39% |
| 2012-04-30 | GBX4.41 Million ≈ $536.08 |
GBX-1.08 Million ≈ $-131.53 |
-0.245x | -37.30% |
| 2011-04-30 | GBX4.53 Million ≈ $551.54 |
GBX-810.00K ≈ $-98.55 |
-0.179x | -61.09% |
| 2010-04-30 | GBX4.16 Million ≈ $505.67 |
GBX-461.00K ≈ $-56.09 |
-0.111x | +46.35% |
| 2009-04-30 | GBX3.82 Million ≈ $464.91 |
GBX-790.00K ≈ $-96.12 |
-0.207x | +34.06% |
| 2008-04-30 | GBX7.22 Million ≈ $878.59 |
GBX-2.26 Million ≈ $-275.46 |
-0.314x | +71.32% |
| 2007-04-30 | GBX5.70 Million ≈ $693.16 |
GBX-6.23 Million ≈ $-757.65 |
-1.093x | -303.88% |
| 2006-04-30 | GBX14.48 Million ≈ $1.76K |
GBX-3.92 Million ≈ $-476.83 |
-0.271x | 0.00% |
| 2005-04-30 | GBX14.48 Million ≈ $1.76K |
GBX-3.92 Million ≈ $-476.83 |
-0.271x | -5819.15% |
| 2004-04-30 | GBX10.99 Million ≈ $1.34K |
GBX52.00K ≈ $6.33 |
0.005x | +100.44% |
| 2003-04-30 | GBX546.00K ≈ $66.43 |
GBX-592.00K ≈ $-72.03 |
-1.084x | +4.59% |
| 2002-04-30 | GBX909.00K ≈ $110.60 |
GBX-1.03 Million ≈ $-125.69 |
-1.136x | -23.10% |
| 2001-04-30 | GBX1.30 Million ≈ $158.29 |
GBX-1.20 Million ≈ $-146.13 |
-0.923x | -- |
About ANGLE plc
ANGLE plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis. It also provides Portrait+ C… Read more